Brief: Elevation Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Achievements
06/03/2025 21:42
March 6 (Reuters) - Elevation Oncology Inc ELEV.O: ELEVATION ONCOLOGY Q4 OPERATING EXPENSES USD 10.642 MILLION ELEVATION ONCOLOGY Q4 BASIC EPS USD -0.18 ELEVATION ONCOLOGY Q4 INCOME FROM OPERATIONS USD -10.642 MILLION ELEVATION ONCOLOGY Q4 PRETAX PROFIT USD -10.427 MILLION ELEVATION ONCOLOGY Q4 NET INCOME USD -10.436 MILLION Source text: ID:nPn2yqVtWa Further company coverage: ELEV.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Elevation Oncology
See all newsBrief: Elevation Oncology Terminates License Agreement With CSPC Megalith Biopharmaceutical
U.S. RESEARCH ROUNDUP- Crane, Ryder System, Terex
Brief: Elevation Oncology Says Concentra To Buy Elevation Oncology For $0.36 Per Share Plus CVR
Elevation Oncology Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Elevation Oncology Inc - To Prepay Term Loan Under Loan & Security Agreement Dated July 27, 2022 - SEC Filing